NCT05918523View on ClinicalTrials.gov

A Long-Term Follow-Up Study of Participants Exposed to REACT

RecruitingOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

December 11, 2023

Primary Completion Date

January 31, 2028

Study Completion Date

March 31, 2028

Conditions
Diabetic Kidney DiseaseChronic Kidney Diseases
Interventions
BIOLOGICAL

Renal Autologous Cell Therapy (REACT)

No interventions in this trial

Trial Locations (1)

83642

RECRUITING

Boise Kidney & Hypertension Institute, Meridian

Sponsors

Lead Sponsor

Prokidney
All Listed Sponsors
lead

Prokidney

INDUSTRY

NCT05918523 - A Long-Term Follow-Up Study of Participants Exposed to REACT | Biotech Hunter | Biotech Hunter